Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $1,679 - $2,800
-101 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $54,648 - $90,235
-2,640 Reduced 96.32%
101 $3,000
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $14,001 - $20,815
735 Added 36.64%
2,741 $59,000
Q2 2021

Aug 16, 2021

BUY
$18.93 - $25.65 $9,521 - $12,901
503 Added 33.47%
2,006 $51,000
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $17,825 - $32,720
1,503 New
1,503 $27,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $2,809 - $6,591
-892 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $4,468 - $7,278
892 New
892 $7,000
Q1 2019

May 15, 2019

SELL
$3.56 - $4.82 $1,634 - $2,212
-459 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.04 - $6.75 $1,854 - $3,098
459 New
459 $2,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.